ABEQUOLIXRON - PharmaKB

ABEQUOLIXRON

Abequolixron is a small molecule pharmaceutical. It is currently being investigated in clinical studies.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

No data

Indications Phases 3

No data

Indications Phases 2

No data

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Non-small-cell lung carcinoma	D002289	—	—	2	—	—	—	—	2
Lung neoplasms	D008175	HP_0100526	C34.90	2	—	—	—	—	2
Recurrence	D012008	—	—	1	—	—	—	—	1
Endometrial neoplasms	D016889	EFO_0004230	—	1	—	—	—	—	1
Small cell carcinoma	D018288	—	—	1	—	—	—	—	1

Indications Without Phase

No data

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	ABEQUOLIXRON
INN	abequolixron
Description	Abequolixron is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification	Small molecule
Drug class	liver X nuclear hormone (LXR) receptor agonists
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	C[C@H](CCOc1cccc(CC(=O)O)c1)N(Cc1cccc(C(F)(F)F)c1Cl)CC(c1ccccc1)c1ccccc1